Literature DB >> 19559726

Exogenous HIV-1 Vpr disrupts IFN-alpha response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay.

Henoch Sangjoon Hong1, Nupur Bhatnagar, Matthias Ballmaier, Ulrich Schubert, Peter Henklein, Thorsten Volgmann, Hans Heiken, Reinhold E Schmidt, Dirk Meyer-Olson.   

Abstract

HIV Vpr is known for its immunomodulatory capacities including its impairment of NK cell functions. However, the role of pDCs in this context remains elusive. We show that synthetic Vpr substantially inhibits type I IFN production by pDCs without inducing apoptosis in pDCs. Furthermore, we found that exogenous Vpr compromises subsequent pDC/NK interplay as shown by diminished IFN-gamma production by NK cells. Thus, Vpr-mediated dysregulation of IFN-alpha and IFN-gamma production affects key components of the innate immune response supporting an essential role of Vpr in HIV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559726     DOI: 10.1016/j.imlet.2009.06.008

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  11 in total

1.  Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.

Authors:  Ferdinand Roesch; Léa Richard; Réjane Rua; Françoise Porrot; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

2.  Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.

Authors:  Caitlin M Miller; Hisashi Akiyama; Luis M Agosto; Ann Emery; Chelsea R Ettinger; Ronald I Swanstrom; Andrew J Henderson; Suryaram Gummuluru
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

Review 3.  Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.

Authors:  Patricia Fitzgerald-Bocarsly; Evan S Jacobs
Journal:  J Leukoc Biol       Date:  2010-02-09       Impact factor: 4.962

4.  HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16+ NK cells.

Authors:  Henoch S Hong; Johanna M Eberhard; Phillip Keudel; Benjamin A Bollmann; Matthias Ballmaier; Nupur Bhatnagar; Margot Zielinska-Skowronek; Reinhold E Schmidt; Dirk Meyer-Olson
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

Review 5.  Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?

Authors:  Diana Ayinde; Claire Maudet; Catherine Transy; Florence Margottin-Goguet
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

6.  Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16⁺ NK cell-like phenotype and correlates with HIV viral load.

Authors:  Henoch S Hong; Fareed Ahmad; Johanna M Eberhard; Nupur Bhatnagar; Benjamin A Bollmann; Phillip Keudel; Matthias Ballmaier; Margot Zielinska-Skowronek; Reinhold E Schmidt; Dirk Meyer-Olson
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

Review 7.  HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention.

Authors:  Michael Kogan; Jay Rappaport
Journal:  Retrovirology       Date:  2011-04-13       Impact factor: 4.602

8.  Effect of type-I interferon on retroviruses.

Authors:  Esperanza Gómez-Lucía; Victorio M Collado; Guadalupe Miró; Ana Doménech
Journal:  Viruses       Date:  2009-10-27       Impact factor: 5.048

9.  HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2.

Authors:  Roland N Wagner; John C Reed; Sumit K Chanda
Journal:  Retrovirology       Date:  2015-08-22       Impact factor: 4.602

10.  T-Cell Signaling in HIV-1 Infection.

Authors:  Wasim Abbas; Georges Herbein
Journal:  Open Virol J       Date:  2013-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.